相关实验视频

Updated: Sep 15, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

针对帕金森病的SNCA向表观基因组疗法减轻了小鼠模型中的病理和行为干扰

Bernadette O'Donovan, Joseph Rittiner, Suraj Upadhya

bioRxiv : the preprint server for biology

|July 16, 2025

概括

这项研究介绍了一种针对α-synuclein (SNCA) 的新型表观基因组疗法,用于治疗帕金森病 (PD). 在PD小鼠模型中,该疗法成功降低了SNCA表达,并改善了PD小鼠模型中的运动功能,显示出治疗潜力.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

过度表达的α-synuclein (SNCA) 是帕金森病 (PD) 发病的一个关键因素.
降低SNCA的调节为PD提供了一个有前途的治疗途径.

研究的目的:

开发和评估一种针对SNCA的表观基因组疗法,用于PD治疗.
评估这种治疗在新型PD小鼠模型中的疗效和安全性.

主要方法:

开发一个全在一体的透视病毒载体 (LV) 系统,使用已停用的CRISPR/Cas9 (dCas9) 向SNCA内核1.1.
通过LV.提供DNMT3A或KRAB/MeCp2-TRD抑制器域.
在一个PD小鼠模型中进行评估,该模型被设计为表达人类A53T-SNCA.

主要成果:

这两种治疗性LV都减少了SNCA在黑色物质 (SN) 中的表达.
LV/dSaCas9-KRAB-MeCP2 ((TRD) 显示出优异的抑制,减少了病态的α-synuclein聚合和酸化.
在接受治疗的小鼠中观察到显著的运动功能的改善和铁氨酸氧酶表达的保存.
安全性评估表明,对血细胞计数,血清化学或体重没有任何不良影响.

结论:

这项研究在一种PD小鼠模型中提供了SNCA向的表观基因组治疗的体内概念证明.
开发的系统证明了对帕金森病和相关的同核蛋白病变的治疗潜力.
这项研究为未来的临床前研究奠定了基础,旨在研究新的药物启用.

更多相关视频

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.